X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Aurobindo Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs AUROBINDO PHARMA - Comparison Results

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES AUROBINDO PHARMA ALKEM LABORATORIES/
AUROBINDO PHARMA
 
P/E (TTM) x - 18.0 - View Chart
P/BV x 6.2 5.8 106.5% View Chart
Dividend Yield % 0.7 0.4 196.4%  

Financials

 ALKEM LABORATORIES   AUROBINDO PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
AUROBINDO PHARMA
Mar-16
ALKEM LABORATORIES/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,5891,541 103.1%   
Low Rs1,232582 211.7%   
Sales per share (Unadj.) Rs417.5237.5 175.8%  
Earnings per share (Unadj.) Rs56.333.9 166.2%  
Cash flow per share (Unadj.) Rs64.740.6 159.5%  
Dividends per share (Unadj.) Rs12.702.50 508.0%  
Dividend yield (eoy) %0.90.2 382.2%  
Book value per share (Unadj.) Rs292.9120.6 242.9%  
Shares outstanding (eoy) m119.57585.17 20.4%   
Bonus/Rights/Conversions -PREF-  
Price / Sales ratio x3.44.5 75.6%   
Avg P/E ratio x25.131.3 80.0%  
P/CF ratio (eoy) x21.826.2 83.3%  
Price / Book Value ratio x4.88.8 54.7%  
Dividend payout %22.67.4 305.6%   
Avg Mkt Cap Rs m168,653621,041 27.2%   
No. of employees `000NA13.3 0.0%   
Total wages/salary Rs m9,17115,508 59.1%   
Avg. sales/employee Rs ThNM10,457.6-  
Avg. wages/employee Rs ThNM1,167.1-  
Avg. net profit/employee Rs ThNM1,491.6-  
INCOME DATA
Net Sales Rs m49,915138,961 35.9%  
Other income Rs m1,6451,663 98.9%   
Total revenues Rs m51,561140,624 36.7%   
Gross profit Rs m8,48232,056 26.5%  
Depreciation Rs m1,0063,926 25.6%   
Interest Rs m6712,568 26.1%   
Profit before tax Rs m8,45127,225 31.0%   
Minority Interest Rs m-11439 -291.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6067,444 21.6%   
Profit after tax Rs m6,73119,820 34.0%  
Gross profit margin %17.023.1 73.7%  
Effective tax rate %19.027.3 69.5%   
Net profit margin %13.514.3 94.5%  
BALANCE SHEET DATA
Current assets Rs m27,062100,015 27.1%   
Current liabilities Rs m15,32474,759 20.5%   
Net working cap to sales %23.518.2 129.4%  
Current ratio x1.81.3 132.0%  
Inventory Days Days67107 61.9%  
Debtors Days Days41110 37.7%  
Net fixed assets Rs m12,61052,350 24.1%   
Share capital Rs m239585 40.9%   
"Free" reserves Rs m34,49067,707 50.9%   
Net worth Rs m35,02770,567 49.6%   
Long term debt Rs m1,2128,472 14.3%   
Total assets Rs m54,387156,994 34.6%  
Interest coverage x13.611.6 117.2%   
Debt to equity ratio x00.1 28.8%  
Sales to assets ratio x0.90.9 103.7%   
Return on assets %13.614.3 95.4%  
Return on equity %19.228.1 68.4%  
Return on capital %24.937.7 65.9%  
Exports to sales %12.951.0 25.4%   
Imports to sales %3.118.8 16.4%   
Exports (fob) Rs m6,46170,927 9.1%   
Imports (cif) Rs m1,54026,193 5.9%   
Fx inflow Rs m6,56371,015 9.2%   
Fx outflow Rs m3,01228,799 10.5%   
Net fx Rs m3,55242,216 8.4%   
CASH FLOW
From Operations Rs m7,25917,596 41.3%  
From Investments Rs m1,864-13,801 -13.5%  
From Financial Activity Rs m-9,273-198 4,676.1%  
Net Cashflow Rs m-1503,597 -4.2%  

Share Holding

Indian Promoters % 66.9 54.1 123.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 8.0 416.4%  
FIIs % 0.0 27.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 10.2 -  
Shareholders   68,381 69,601 98.2%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   AJANTA PHARMA  GLENMARK PHARMA  SUN PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  

Compare ALKEM LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Aug 17, 2017 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 5-YR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS